QualityStocks
  The QualityStocks Daily Newsletter for Tuesday, July 13th, 2010 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters

1.

Dr. Stock Picks (EEE)

2.

Wise Alerts (CSKH)

3.

Stock Twiter (LBSRE)


The QualityStocks Daily

Daulton Capital Corporation (DUCP)

The Subway and Shazamstocks reported recently on Daulton Capital Corporation (DUCP), The Stock Scout, Penny Stock Finder, Stock Preacher, Cool Penny Stocks, Penny Invest, Stock Rich, HotOTC.com, OTCReporter.com, and StockEgg.com did previously, and we highlight the Company as "One to Watch", here at the QualityStocks Daily Newsletter.

Daulton Capital Corporation is a natural resource finance company that trades on the OTC Bulletin Board. The Company focuses on precious and base metals as well as oil and gas opportunities. Company Management’s corporate philosophy is to be a Project Generator. Their goal is option/joint venturing projects with major and junior natural resource companies from inception through to production. Daulton Capital Corporation has their headquarters in Las Vegas, Nevada.

The Company has acquired property rights in the Yukon. They continue to focus on acquiring and/or funding additional resource projects. They are working to expand exploration while continuing to seek special situations and unique opportunities in under funded projects within the resource sector.

Daulton Capital Corporation is currently negotiating an option agreement on two key Gold Projects located in the Yukon Territory, Canada. The Hunker Project is in the heart of the famous Klondike Placer Gold District. The Balarat Project is in the White Gold District. This newly discovered and internationally recognized area is the same district where Underworld Resource’s recent drill results incepted grades of 103 meters averaging 3.4 g/t Au.

The Hunker Project has a geologist engaged in preparing a NI 43-101 report. The Balarat Property is to begin a three Phase work program. Both properties are in prolific gold producing areas, with recent discoveries on neighboring properties.

The Hunker Project consists of 121 Yukon Quartz Mining Claims located in the Dawson Mining District, Yukon Territory Canada. The claim block is 15 miles southeast of Dawson City. It stands at 6,000 acres or 24 square kilometers. It straddles Hunker Creek, one of the Klondike’s famous gold producing placer creeks.

The Balarat Project consists of 38 Yukon Quartz Mining Claims located in the Dawson Mining District, Yukon Territory, Canada. The claim block is three miles southeast of Underworld Resources, Black Fox Property. The claim block covers 1,900 acres or 7.6 square kilometers. It straddles Balarat Creek, one of the main placer gold producing placer creeks in the Thistle Area (White Gold District).

We're keeping an eye on Daulton Capital Corporation (DUCP), and we're tracking them on our radar screens as "One to Watch' this week, here at the QualityStocks Daily Newsletter.

Daulton Capital Corporation (DUCP) closed Tuesday's trading session at $0.20, up 11.11%, on 100,000 volume with 8 trades. The stock’s average daily volume over the past 60 days is 86,097 with a 52-week low/high of $0.075/$0.75.

Cano Petroleum Inc. (CFW)

HotOTC.com and Stock Rich reported previously on Cano Petroleum Inc. (CFW), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Founded in 1997, Cano Petroleum, Inc. is an independent Texas-based energy producer that trades on the NYSE Amex.  The Company has properties in the mid-continent region of the United States. Their primary focus is on increasing domestic production from proven fields using enhanced recovery methods. Cano Petroleum Inc. has their corporate headquarters in Fort Worth, Texas.

The Company's focus on mature oil fields with proven reserves eliminates exploratory and international development risks. Mr. Jeff Johnson, an oil and gas entrepreneur with a finance background founded the Company in 2004. He saw the opportunity to capitalize on oil and gas market conditions by acquiring mature U.S. oil fields and applying state–of–the–art recovery techniques to increase and accelerate production. He secured $8.75 million in startup capital in 2004 to develop Cano. He brought the Company public and began trading on the OTC Bulletin Board.

Cano Petroleum Inc. has acquired many mature domestic oil fields since their inception. The Company believes these are suitable for secondary waterflood and/or enhanced oil recovery applications. Their oil and gas assets, located in Texas, New Mexico and Oklahoma, are proven, mature oil fields that possess significant proven reserves, and a high ratio of probable reserves.

Prior to acquisition, Cano’s assets are subjected to a rigorous in–house evaluation, as well as 3rd party engineering, to determine their suitability for secondary or tertiary recovery programs. The Company's business strategy is to increase production and asset value by exploiting the probable reserves through the application of secondary and enhanced oil recovery (EOR) methods.

Cano Petro of New Mexico, Inc., their wholly owned subsidiary, acquired certain oil and gas properties in the Permian Basin in March 2007. The Cato Properties include approximately 20,000 acres across three fields in Chaves and Roosevelt Counties, New Mexico. The prime asset is the roughly 15,000-acre Cato Field. It produces from the historically prolific San Andres formation, which has been successfully waterflooded in the Permian Basin for more than 30 years.

In May 2004, Cano Petroleum, Inc. acquired certain properties in Lincoln County, Oklahoma. These are the "Davenport Properties". In March 2005, in connection with their acquisition of Square One Energy, Inc. they acquired a 100 percent working interest in 11,068 acres in mature oil fields in central Texas: the "Desdemona Properties".

In September 2004, Cano acquired more than 220 wells producing from the Bartlesville Sandstone in Nowata County, Oklahoma. These are the "Nowata Properties". In November 2005, via their acquisition of W.O. Energy of Nevada, Inc., they acquired 480 producing wells, 40 water disposal wells and 380 idle wells on approximately 20,000 acres in Carson, Gray and Hutchinson Counties, Texas: the "Panhandle Properties". In addition, included in the acquisition were 10 workover rigs and related equipment.

Yesterday, Cano Petroleum, Inc. announced that the Board of Directors of Cano is actively involved in ongoing discussions with Resaca Exploitation, Inc. These discussions concern alternative financing structures that would permit the consummation of the merger of the two companies. Cano Petroleum is also continuing to evaluate other options.

Cano Petroleum Inc. (CFW) closed Tuesday's trading session at $0.5681, up 6.19%, on 286,808 volume with 511 trades. The stock’s average daily volume over the past 60 days is 277,518 with a 52-week low/high of $0.47/$1.39.

CEL-SCI Corporation (CVM)

Recently, Ceocast News reported on CEL-SCI Corporation (CVM), Greenbackers, The Street, SmallCap Voice, Microcapalliance, HotOTC.com, Cool Penny Stocks, Penny Invest, Stock Rich, StockEgg.com, OTCReporter.com did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Founded in 1983, CEL-SCI Corporation is developing products that empower immune defenses. The Company's lead product is Multikine®. In Phase II clinical trials Multikine was shown to be safe and well tolerated, and to improve the patients' overall survival by 33 percent at a median of three and a half years following surgery. The expectation is that a pivotal Phase III clinical trial with Multikine in head and neck cancer will start in the second half of this year.

CEL-SCI Corporation trades on the NYSE Amex and they have their headquarters in Vienna, Virginia. They have operations in Vienna, Virginia, and in/near Baltimore, Maryland. Their core capabilities include drug discovery, research, development and manufacturing of complex biological substances. The Company develops novel immune-based therapies that harness the body’s own immune defense system to fight disease. These therapies are effective and non-toxic to the body’s normal cells and organ systems. This is unlike traditional cancer therapies such as chemotherapy, radiation and surgery, which are most often highly toxic or damaging.

The Company is also developing an immunotherapy (LEAPS-H1N1-DC) to treat H1N1 hospitalized patients. They are developing a vaccine (CEL-2000) for Rheumatoid Arthritis using their LEAPS technology platform. The LEAPS-H1N1-DC treatment involves non-changing regions of H1N1 Pandemic Flu, Avian Flu (H5N1), and the Spanish Flu. CEL-SCI scientists have a deep concern about the creation of a new more virulent hybrid virus through the combination of H1N1 and Avian Flu, or maybe Spanish Flu. This investigational treatment is currently undergoing testing in a clinical study at Johns Hopkins University.

In May, CEL-SCI Corporation reported financial results for the quarter ended March 31, 2010. The Company reported that net loss for the three months ended March 31, 2010 was ($0.7 million) versus a loss of ($2.1 million) during the same three months in fiscal year 2009. The loss during the quarter ended March 31, 2010 was reduced by a gain on derivative instruments of $4.5 million. Net income available to shareholders for the six months ended March 31, 2010 was $17 million versus a loss of ($4.3 million) during the same six months in fiscal year 2009. The gain on net income for the six months ended March 31, 2010 was due to derivative accounting.

In late June, CEL-SCI Corporation and researchers at the Northeastern Ohio Universities Colleges of Medicine and Pharmacy (NEOUCOM) jointly announced that a LEAPS™–based vaccine (Ligand Epitope Antigen Presentation System) study demonstrated the technology’s potential using dendritic cells to stimulate the immune system to fight viral illnesses and other diseases. Results of the study were selected for an oral presentation at the Federation of Clinical Immunology Societies (FOCIS) Annual Meeting in Boston, Massachusetts, June 27, 2010. The results are to be published in Vaccine, a peer-reviewed, pre-eminent journal for vaccines and vaccination.

CEL-SCI Corporation (CVM) closed today's trading at $0.5381, up 7.62%, on 555,076 volume with 694 trades. The stock’s average daily volume over the past 60 days is 983,759 with a 52-week low/high of $0.38/$2.10.

Hauppauge Digital Inc. (HAUP)

Recently, All About Trends, Greenbackers, Stock Fortune Teller, and Trading Markets reported on Hauppauge Digital Inc. (HAUP), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Hauppauge Digital Inc. is a leading developer of analog and digital TV receiver products. These are for the personal computer market. The Company operates through their subsidiaries Hauppauge Computer Works, Inc. and Hauppauge Digital Europe SARL.

Trading on the NASDAQ Global Market, they have their corporate headquarters in Hauppauge, New York. They also have administrative offices in Luxembourg, Ireland and Singapore, sales offices in Germany, London, Paris, The Netherlands, Sweden, Italy, Spain, Singapore, Taiwan, and California. In addition, they have research and development centers in Hauppauge, New York, Taipei, Taiwan and Braunschweig, Germany.

Hauppauge Digital Inc. designs and develops analog and digital TV receivers. These products allow PC users to watch television on their PC screen in a resizable window. They enable the recording of TV shows to a hard disk, digital video editing, video conferencing, receiving of digital TV transmissions, and the display of digital media stored on a computer to a TV set via a home network.

The Company's PCTV product line, acquired from Avid Technology, Inc and certain of their affiliates in December 2008, has established itself as Hauppauge Digital's premium TV tuner product line. The Company continues to invest in research and development at their three R&D centers. This is to support their sales and gross profit growth.

Hauppauge Digital Inc. recently introduced their WinTV Extend software. This software brings live TV to portable devices such as the iPhone and iPad. Under development are new high definition TV tuners for the European, North American and Australian markets. Additionally, they are getting ready to launch a TV tuner for the new mobile digital TV standard in the United States, ATSC M/H.

In May, Hauppauge Digital Inc. reported financial results for the second fiscal quarter and six-month period ended March 31, 2010. Net sales were $13.8 million for the second quarter of fiscal 2010. This represents an increase of approximately 8.75 percent from the $12.7 million reported for the previous year’s second fiscal quarter. They had a net loss of $902,873 for the second quarter of fiscal 2010, compared to a net loss of $1,932,070 for the second quarter of fiscal 2009.

Net sales were $31.7 million for the six months ended March 31, 2010. This is an increase of approximately 5.67 percent from the $30.0 million reported for the six months ended March 31, 2009. They had a net loss of $1,237,424 for the six months ended March 31, 2010 compared to a net loss of $3,704,383 for the six months ended March 31, 2009.

Hauppauge Digital Inc. (HAUP) closed Tuesday's session at $1.88, up 6.21%, on 330,069 volume with 1,223 trades. The stock’s average daily volume over the past 60 days is 1,350,812 with a 52-week low/high of $0.6025/$4.85.

Dune Energy Inc. (DNE)

CRWE Finance reported recently on Dune Energy Inc. (DNE), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.

Founded in 1998, Dune Energy Inc. is an independent energy company. They engage in the exploration, development, acquisition, and exploitation of natural gas and crude oil properties along the Louisiana/Texas Gulf Coast. Dune operates more than 90 percent of their production and usually maintains a 100 percent Working Interest. 

Proved reserves as of January 1, 2010 totaled 105.5 Bcfe consisting of 62.3 Bcf of natural gas and 7.2 MMbbls of oil.  Dune continues to exploit their existing asset base, seek accretive acquisitions, and enter into additional joint venture drilling programs. The Company has their headquarters in Houston, Texas.

The Company recently provided an operations update. The Wieting #33 at the Chocolate Bayou field is drilling below 10,500 feet.  The anticipation is that casing will be set at approximately 11,600 feet and again at approximately 12,500 feet.  The Chocolate Bayou prospect has potential reserves of approximately 60 Bcfe, which will undergo testing by the #33 well. 

Dune Energy Inc. will have a 50 percent working interest in the reserves and production associated with this high potential prospect at casing point.  They anticipate, this summer, development wells undergoing drilling at Live Oak field and Bayou Couba. In addition, post hurricane season, they anticipate commencing a 2 to 3 well program at Garden Island Bay.

On June 30, 2010, Dune Energy, Inc. announced that they closed on the $30 million sale of South Florence field and entered into a fifth amendment to their revolving credit agreement with their Wells Fargo Foothill. They closed the sale of their South Florence field to a private party on June 29, 2010 for $30 million with an effective date of May 1, 2010.  They expect to use proceeds from the sale to temporarily, or permanently, repay borrowings under their $40 million revolving credit facility, and/or to invest in new assets or fund maintenance, repair or improvement of their existing properties and assets.

Mr. James A. Watt, President and Chief Executive Officer stated in June, "The sale of South Florence and the fifth amendment to the revolver provide liquidity to implement our drilling program to add new reserves and production to replace those sold.  Our direct investments in the drilling program will be controlled to provide sufficient liquidity to satisfy obligations to note holders and remain within the covenants of our amended revolver.  We continue working with industry partners to structure deals to provide capital for new drilling opportunities within our existing asset base."

Today, Dune Energy Inc. (DNE) closed at $0.14, up 27.27%, on 781,314 volume with 412 trades. The stock’s average daily volume over the past 60 days is 705,119 with a 52-week low/high of $0.0801/$1.25.

Great Basin Gold Ltd. (GBG)

SmallCap Voice reported recently on Great Basin Gold Ltd. (GBG), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Trading on the NYSE Amex, Great Basin Gold Ltd. is working to become a mid-tier gold producer. They are working to achieve this through a well-defined strategy of developing their highly-prospective projects into high margin productive units, and continuing to increase their resource base through focused exploration programs. In addition, they are looking to acquire prospective companies and/or assets. Great Basin Gold Ltd. has their headquarters in Sandton, South Africa, and an office in Vancouver, British Columbia.

The Company is currently in late stage development at two projects in the world’s two most well-known gold producing regions, with a substantial resource base of 13 million ounces in the measured and indicated category. The Hollister project is on the Carlin Trend in Nevada, and the Burnstone project, is on the Witwatersrand Basin in South Africa. Feasibility studies have completed on both projects, and they are in the underground access and pre-production phase.

On July 12, 2010, Great Basin Gold Ltd. announced progress in the delivery of the capital projects at their Burnstone Mine development project in South Africa. Eskom, the state energy provider, informed the Company that final arrangements have been made to tie the Burnstone project in to the national electricity grid on August 8, 2010. This is a delay of approximately two weeks with a resultant delay in plant start up.

The establishment of bulk electrical power infrastructure to the Burnstone Mine by Eskom is well advanced. The main distribution substation at Burnstone site is complete. In addition, the receiving infrastructure being part of the Eskom line project is ready to receive electrical power.

Ferdi Dippenaar, President and CEO, commented: "Although delayed, finalization of the power supply from Eskom is a significant step towards the commissioning of the Burnstone metallurgical plant. Internal delays at Eskom impacted on its previous commitments to deliver power to site by the end of June 2010. Fortunately, the delay in commissioning the mill is only limited to two weeks, and is not expected to significantly impact on the planned ore throughput."

Great Basin Gold Ltd. (GBG) closed today at $1.82, up 1.11%, on 1,022,004 volume with 2,409 trades. The stock’s average daily volume over the past 60 days is 1,572,585 with a 52-week low/high of $1.22/$2.04.

Kendle International Inc. (KNDL)

We are highlighting Kendle International Inc. (KNDL), here at the QualityStocks Daily Newsletter.

Headquartered in Cincinnati, Ohio, Kendle International Inc. is a leading, global full-service clinical research organization. The Company provides the full range of early- to late-stage clinical development services for the global biopharmaceutical industry.  Kendle International Inc. trades on the NASDAQ Global Select Market.

The Company's focus is on innovative solutions that reduce cycle times for their customers and speed up the delivery of life-enhancing drugs to market for the benefit of patients globally. Kendle International is one of the world's largest global providers of Phase I-IV services. They offer experience spanning more than 100 countries. They also offer industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet their customers' clinical development challenges.

Kendle International Inc. operates through two segments. These are Early Stage and Late Stage. The Early Stage segment focuses on the high-end scientific exploratory medicine area, from first-in-human studies to proof-of-concept stages. The Early Stage segment also supports Phase I studies in established compounds. These include bioequivalence and pharmacokinetics studies.

The Late Stage segment conducts Phase II to IV clinical trials, and provides a range of services. These services include clinical monitoring, investigator recruitment, patient recruitment, data management, and study reports to assist customers with their drug development process.

The Late Stage segment also oversees various steps of a study, from award to close out of a study; designs and conducts Phase IIIB and IV studies, focuses on health economics and outcomes research, observational studies, scientific events, and medical education services. They also provide services to the federal government and health care foundation oriented organizations.

This segment also offers regulatory and consulting services at every stage of drug and device development. They also design clinical programs and clinical trial protocols, reviews programs, and provide gap analysis to assist sponsors in achieving their clinical development strategies.

Furthermore, the Late Stage segment offers consulting services for nonclinical development for small molecules, biologicals, vaccines, and devices. They assist with the U.S. Food and Drug Administration (FDA) application process, and assist customers with the collection, analysis, and reporting of drug safety data. They also offer statistical support for Phase I to IV clinical trials and submissions.

In mid-June, the Company announced that they now offer Brain Network Activation (BNA) imaging.  This provides a non-invasive platform for mapping, monitoring and understanding brain electro-physiological network activity in response to cognitive or physiological stimuli. ElMindA, a medical technology development company based in Herzliya, Israel, developed the BNA imaging technology.

Exclusively licensed to Kendle's early stage development efforts, this solution reveals electrophysiological neural networks. It does so through using an innovative set of signal processing and pattern recognition techniques that combine the high temporal resolution of EEG with the spatial resolution of fMRI.  The result is a three-dimensional image of neuronal connectivity and synchronization providing sensitive, specific and reproducible data on drug effects essential for early stage development.

On June 22, 2010, Kendle announced that they opened their new operations center in the Special Economic Zone (SEZ) of the Ahmedabad-Gandhinagar Knowledge Corridor in India.  The new SEZ center represents an important and strategic investment for Kendle. It demonstrates the Company's commitment to invest further in the Asia/Pacific region to meet customer needs.  The center opened Monday, June 21, following a dedication and lamp lighting ceremony.

Kendle International Inc. (KNDL) closed Thursday's trading at $12.37, up 2.49%, on 157,279 volume. The stock's 52-week low/high is $9.57/$21.79.

Standard Oil Company USA, Inc. (SOCU)

Today we are highlighting Standard Oil Company USA, Inc. (SOCU) as "One to Watch" this week, here at the QualityStocks Daily Newsletter.

Standard Oil Company USA, Inc. is a leading independent energy company that trades on the Pinksheets.  The Company focuses on the acquisition, development, production, exploration for, and the sale of oil, natural gas and hydrocarbon liquids. They are currently evaluating drilling projects both domestically and in the near future, internationally. The management of the Company has significant years of experience in the oil and gas industry. Standard Oil Company USA, Inc. has their corporate headquarters in Dallas, Texas.

Formerly known as International Energy Group Ltd., Inc., the Company changed their name to Standard Oil Company USA, Inc. Their symbol changed to "SOCU" effective with the commencement of trading on Thursday, May 13, 2010.

In early June 2010, Standard Oil Company USA, Inc. announced a signed agreement to acquire Home Creek Energy LLC. A Texas based company, Home Creek Energy, LLC, holds oil and gas leases of almost 2,348 acres in Texas. Most of the leases lie in the Lindsea Bea (Bend Conglomerate) field. Other assets include in this purchase are 18 x 210 bbl tanks w/walkways and stairs, 5 total fiberglass tanks with a total capacity of 1140 bbl, 8 heater treaters, and other oil equipment essential to oil production.

In addition, last month, the Company announced the execution of a binding Letter of Intent to purchase the War Creek Project. This Project is in War Creek and Mill Creek Districts, Breathitt County, Kentucky. Recorded from War Creek Energy, LLC, this leasehold includes 400 acres plus many production wells with some of the wells being fully equipped with tank batteries. Once Standard Oil Company USA, Inc. takes final ownership of these leases, surrounding acreage will become available.

On June 24, 2010, Standard Oil Company USA, Inc.'s Chairman Ronald Brooks announced the purchase of 24 Revenue Producing Oil/Gas Leases in Latimer County, Oklahoma. These are from AAT Investments, Inc. of Oklahoma City, Oklahoma. Chesapeake Energy (www.chk.com) presently operates the 24 leases. These leases represent about 4,000 acres. The closing date of this purchase agreement is set for July 15, 2010.

We have Standard Oil Company USA, Inc. (SOCU) locked on our radars screens as "One to Watch" this week, here at the QualityStocks Daily Newsletter.

Standard Oil Company USA, Inc. (SOCU) closed Tuesday's session at $0.0320, down 8.57%, on 29,000 volume with 4 trades. The stock’s average daily volume over the past 60 days is 152,823 with a 52-week low/high of $0.0004/$0.115.

The QualityStocks Company Corner

VizStar, Inc. (VIZS)

The QualityStocks Daily Newsletter would like to spotlight VizStar, Inc. (VIZS) Today, VizStar, Inc. closed trading at $0.50, up 4.17%, on 27,403 volume with 18 trades. The stock’s average daily volume over the past 60 days is 56,770 with a 52-week low/high of $0.0162/$0.65.

VizStar, Inc. (VIZS) announced this morning that the company has opened a new office in Los Angeles, CA. Strategically located near Beverly Hills, it is expected that the office will further expand Celestial Jet’s existing business by capitalizing on the massive amount of private air travel conducted in the region.

VizStar, Inc. (VIZS) is a premier aviation charter broker focused on delivering a new and unparalleled way to experience private jet travel. The company delivers this unmatched service without monthly membership fees, initiation fees, long term commitments or capital investment, while delivering typical savings of 20-30% when compared to other charter or fractional companies in the market place.

Within as little as four hours notice, Celestial Jets can make all the travel arrangements for their client's next trip. Whether it is a short hop or an intercontinental journey, business or pleasure, each and every detail is attended according to the client's specific requirements. With access to nearly 6,000 qualified aircraft, ranging from light, mid, heavy or jumbo jets, Celestial Jets is capable of serving any potential client.

The company adheres to the highest and most up-to-date safety standards of today. Each aircraft, in correspondence with FAA law, is flown by two pilots, each with outstanding credentials and type rated for the aircraft they are flying. Celestial Jets also abides by the strict protocol of the Transportation Security Administration, the Federal Bureau of Investigation and all other federal and local law enforcement agencies.

Celestial Jets' service goes much further than just the flight, offering chauffeured limousine pickup with planeside drop off, world class catering, hotel and resort accommodations, and restaurant reservations, in addition to technical support, accounting, legal, or secretarial services, spa treatments, event planning, and childcare. Leaving no detail to chance or any expectation left unmet, Celestial Jets takes care of everything at the most competitive prices in the industry. Disclaimer

VizStar, Inc. Blog

VizStar, Inc. News:

UPDATE VizStar, Inc. Appoints Aviation Expert Thomas Tamulinas as Director of Flight Operations

VizStar, Inc. Begins Trading of Common Stock after Successful Acquisition of Celestial Jets

Celestial Jets Closes Merger and Acquisition of VizStar, Inc.

NetSol Technologies, Inc. (NTWK)

The QualityStocks Daily Newsletter would like to spotlight NetSol sTechnologies, Inc. (NTWK). Today, NetSol Technologies, Inc. closed trading at $0.83, up 8.50%, on 390,256 volume with 488 trades. The stock’s average daily volume over the past 60 days is 188,099 with a 52-week low/high of $0.68/$1.31.

NetSol Technologies, Inc. (NTWK) announced the successful implementation of its Financial Suite of financial leasing products by Minsheng Financial Leasing Co., Ltd., a leading financial leasing company in China.

NetSol Technologies, Inc. (NTWK) a worldwide provider of global business services and enterprise application solutions, leverages its BestShoring(TM) practices and highly experienced resources to deliver high-quality, cost-effective solutions. The ir suite of products and services include credit and finance portfolio management systems, hospital/healthcare information management systems (HIMS), SAP consulting and services, custom development, systems integration, and technical services.

NetSol’s commitment to quality is demonstrated by its achievement of the ISO 9001, ISO 27001, and SEI (Software Engineering Institute) CMMI (Capability Maturity Model) Maturity Level 5 assessments, a distinction shared by less than 100 companies worldwide. These distinctions are a result of adhering to rigorous quality standards, resulting in the delivery of solutions that are secure, reliable, properly planned, and meticulously executed.

Serving the global financial, healthcare, insurance, energy, and technology markets, NetSol has operations, offices, and joint ventures in Adelaide, Bangkok, Beijing, Lahore, London, Riyadh, San Francisco, and San Pedro Sula. NetSol Technologies' clients include Fortune 500 manufacturers, global automakers, financial institutions, utilities, technology providers, and government agencies.

NetSol Technologies, Inc. (NTWK), is well positioned with its core product offerings as it continues to expand into new international market opportunities. Looking forward, the company is very optimistic of its short-term and long-term outlook as it sees strong growth in Asia Pacific as well as the South East Asian markets, while also envisioning unlimited potential for its niche solutions and services in the Americas. Disclaimer

NetSol Technologies, Inc. Blog

NetSol Technologies, Inc. News:

NetSol Signs Contract With Sany Corp. of China to Implement NFS Solution

NetSol Technologies' smartOCI(TM) Search Engine Receives SAP Certification

National Automation Services, Inc. Operations and Investor Update

Uranium Energy Corp. (UEC)

The QualityStocks Daily Newsletter would like to spotlight Uranium Energy Corp. (UEC) Today, Uranium Energy Corp. closed trading at $2.45, up 2.08%, on 233,691 volume with 770 trades. The stock’s average daily volume over the past 60 days is 365,938 with a 52-week low/high of $2.10/$4.16.

Uranium Energy Corp. (UEC) is a U.S.-based exploration and development company focused on near-term uranium production in the U.S. The company’s operations are managed by professionals who have earned a reputable profile through many decades of hands-on experience in the key facets of uranium exploration, development and mining.

Uranium Energy controls one of the largest databases of historic uranium exploration and development in the nation. Using this knowledge base, the company has acquired and is advancing exploration properties of merit throughout the southwestern U.S., a region known as being the most concentrated area for uranium mining in the United States.

The Company’s fully licensed and permitted Hobson processing facility is central to all of its projects in South Texas. Well financed to execute on its key programs, Uranium Energy's Palangana is-situ recovery project is fully permitted, and its Goliad in-situ recovery project is in the final stages of mine permitting for production.

The company’s strategy of acquiring exploration databases and leveraging those databases to generate acquisition targets has proven to be effective thus far. With plans to continue aggressively pursuing this strategy, Uranium Energy Corp is well positioned to capitalize on the world’s first significant alternative energy boom. Disclaimer

Uranium Energy Corp. Blog

Uranium Energy Corp. News:

BUYINS.NET Updates Uranium Energy Corp SqueezeTrigger Report

Uranium Energy Corp Discovers New Exploration Zone and Reports Strong Drill Results at Palangana in South Texas

Uranium Energy Corp Initiates Wellfield Development and Construction at Palangana

Cellceutix Corp. (CTIX)

The QualityStocks Daily Newsletter would like to spotlight would like to spotlight Cellceutix Corp. (CTIX). Today, Cellceutix Corp. closed trading at $0.62, for no change, on 2,750 volume with 2 trades. The stock’s average daily volume over the past 60 days is 2,464 with a 52-week low/high of $0.23/$1.01.

Cellceutix Corporation (CTIX) an emerging bio-pharmaceutical company, is in the early stages of receiving an influx of media attention and widespread notoriety within the pharmaceutical industry due to the promising results shown during the early development of a compound for the treatment of autism, KM-391, and the approaching Phase 1 clinical trials of Kevetrin™, the company's compound for the treatment of drug-resistant cancers. In addition to these two, Cellceutix currently manages a portfolio of six other promising compounds.

KM-391, a 100% novel compound, is revolutionary in that it addresses the core issues of autism, unlike the pharmaceuticals presently on the market which merely treat the symptoms that result from autism. Preliminary testing of KM-391 revealed that test animals showed a significant increase in serotonin uptake compared to controls with noticeable and measurable positive therapeutic changes. Cellceutix is rapidly developing KM-391 in response to the public outcries received by the company since the results of early testing had been made publicly available.

Kevetrin, Cellceutix's flagship product, is nearing Phase 1 clinical trials on humans with FDA regulated pre-clinical testing completed and the data being properly compiled for the IND application. While most cancer treatments today are derivatives of other compounds, Kevetrin is completely unique. Multidrug resistance, the principal mechanism by which strains of cancer develop resistance to chemotherapy drugs, is a major factor in the failure of many forms of chemotherapy today and represents a huge need for novel cancer treatments.

Kevetrin has been extensively studied in animal models of lung, breast, and colon cancers, targeting carcinoma strains that have proven resistant to standard therapies available on the market today with the results showing greater tumor growth delay than present therapies and strong efficacy in mouse models with increasing dosages. A successful drug for the treatment of drug-resistant cancers is purported to generate billions of dollars in annual revenues.

The Company has procured leading figures in the health and science arenas to lead its development efforts. The officers and advisors of Cellceutix include pioneers in the fields of cancer and genetics, as well as those who have been integral to mergers, acquisitions and the generation of exorbitant revenues through ground breaking therapies while holding high-level executive and research positions at industry giants such as Pfizer and Eli Lilly. Holding over a century of highly relevant experience in the pharmaceuticals industry, the team has been assembled with the specific goal of duplicating these past successes while revolutionizing much needed treatments for today's most challenging diseases. Disclaimer

Cellceutix Corp. Blog

Cellceutix Corp. News:

Cellceutix Completes All Three Animal Safety Pharmacology Studies for Its Cancer Compound Required by FDA Prior to Filing Investigational New Drug (IND) Application

AllPennyStocks.com News: Drug-Resistant Cancers Now a Focal Point for Progressive Biotechs

AllPennyStocks.com Announces Corporate Write-Up on Cellceutix Corp. (OTCBB:CTIX)

Tombstone Exploration Corp. (TMBXF) Adds Important Nevada Holding To Its Portfolio

Tombstone Exploration Corporation Inc., a metals and minerals exploration and mining company controlling one of the biggest mining properties in southern Arizona, recently announced that it had closed a lease agreement for the Eagleville property in Mineral County, Nevada. The property, on the western edge of Nevada, represents a bit of a shift for the company, which has focused on the Tombstone Mining District in southern Arizona. However, it is a mesothermal gold-silver vein system, representing a mid-stage gold-rich prospect, which, together with the company’s other holdings, enhances the opportunity to take advantage of price increases in both gold and silver.

The Eagleville property is located in the prolific Walker Lane Structural belt that hosts bonanza grade mineralization, such as that seen at Goldfield, Round Mountain, and Paradise Peak gold districts of Nevada. It is approximately 5 miles east of the Kennecott Rawhide gold-silver mine where over 1 million ounces of gold and 9 million ounces of silver have been recovered.

The Eagleville property has historically produced multi-ounce gold ore and chemical grade barite ore. Unofficial records indicate that the average grade of gold ore was approximately 1-2 ounces of gold per ton. Type examples of this style of vein system indicate mineralization extends to depth, and the veins found on the property may be just the upper level of a larger mineralized system.

It is situated in a favorable geological environment where previous mining has taken place. With the extensive surface alteration, historic underground mining, and the property having never been drilled, the project exhibits potential to host significant gold and silver mineralization. Additional work is planned to explore the extension of the Eagleville mineralized systems under the adjacent overburden.

Tombstone CEO, Alan M. Brown, said, “The exploration and development already completed on the Eagleville property are incredible. We are currently forming a team of professionals to execute our exploration activities as we plan our best strategy for development.”

VizStar, Inc. (VIZS) Announces New Office Strategically Located in Los Angeles, California

VizStar, Inc., an upscale aviation charter transportation broker, announced this morning that the company has opened a new office in Los Angeles, CA. Strategically located near Beverly Hills, it is expected that the office will further expand Celestial Jet’s existing business by capitalizing on the massive amount of private air travel conducted in the region.

According to the press release, the new office has been operational and fully functioning since June 21st, 2010 and is capable of offering the company’s unparalleled service with as little as 4 hours lead time to the Los Angeles and surrounding areas. The new business address is:
8335 Sunset Blvd, West Hollywood, CA 90069 Ph: 1-877-421-4825

Celestial Jets has worked diligently to gain clients that travel from the Beverly Hills area, and VizStar seeks to expand that reach into all corners of the Los Angeles/San Fernando Valley. The Company believes that its excellent service should be available unconditionally, with no monthly fees, membership costs, or long-term commitments. Expanding to the Los Angeles area will provide an opportunity to gain customers and enthusiasts to their unparalleled services.

VizStar President and CEO Gary Clyburn Jr. commented, “Not only does this office offer enhanced convenience to our customers, it allows us to easily market to the large enterprises operating in the local area. We feel that our safety and service offerings will persuade new clients to use our services and gain further market penetration on the West Coast.”

Universal Detection Technology (UNDT) Unveils Rapid Mold Detector

Universal Detection Technology, www.udetection.com – the developers of revolutionary monitoring and early warning bio-detectors that have applications from bioterrorism to healthcare, announced a new product today designed to rapidly detect the three biggest indoor mold concerns.

The device uses concepts from immunochromatographic assays (rapid test, sometimes called a hand-held assay or HHA) to offer high-fidelity rapid detection, and is able to detect specific species and sub-species of Aspergillus and Penicillium, as well as species of Stachybotrys (chlorohalonata, microspora, echinata, chartarum and etc.).
These top three serious types of mold are prevalent in buildings that have been flooded and where climate conditions contribute to mold propagation, such as homes flooded in Hurricane Katrina, where such molds pose a serious health risk to occupants.

This device is tailored to meet the requirements of early-warning monitoring, and constitutes a robust, accurate solution for addressing indoor mold-related health-safety concerns:

• Detection results in 15 minutes at or below concentrations of 100k spores per ml.
• Each test individually packaged in a vapor-lock pouch
• Separate detection for each species (Aspergillus, Penicillium and Stachybotrys)
• No cross-reactivity to neighboring strains or household substances
• Designed to be compact and very light, with a 2-year shelf life
CEO of UNDT, Jacques Tizabi, beamed at the debut of this first-of-its-kind mold detector, touting it as an ideal solution for homeowners, who would be able to detect and address mold “in as little as 15 minutes and remediate any mold damage prior to the onset of health complications”.

The Company has really put together an attractive portfolio of bio-detection technology that is continuously being translated into profitable applications like the bacterial spore detector developed with NASA, and on the whole is in prime position to capitalize on emerging opportunities in private or public sector applications like Homeland Security.

A5 Laboratories Inc. (AFLB) Completes Acquisition of Contract Research (CRO) and Interferon Production Technology

Yesterday, A5 Laboratories Inc. announced that they completed the acquisition of the Contract Research (CRO) and Interferon production technology previously announced on May 7, 2010 from Vida Pharma, based in Montreal, Canada. A5 Laboratories plans to secure immediately the intellectual property related to the interferon production technology. They also are working to complete their plans for pilot scale production and commercialization of interferon products for human and veterinary applications.

Dr. Richard Azani, President and CEO of A5 Laboratories Inc. said, “We are very pleased to complete the acquisition of the CRO and Interferon production technology assets. We now have at our disposal the necessary assets to develop and commercialize novel biotechnology products.”

Additionally, with the acquisition of the CRO assets, they have established the capacity for contract analytical, product development, regulatory and testing services in the pharmaceutical and environmental sector.

Headquartered in Lachine, Quebec, Canada, A5 Laboratories Inc. provides contract analytical, regulatory and product development services. Incorporated in Nevada on June 21, 2006, the Company services the pharmaceutical and biotechnology companies in North America. They utilize their research capabilities to license and acquire novel biotechnology products for development and commercialization.
The Company engages in the development and marketing of novel immun- therapeutic applications of a natural Gamma – Interferon (nG-IFN). These applications include the diagnostic, the prevention, and the treatment of various animal and human diseases.

Interferon (IFN) is a type of protein called a cytokine. It is secreted by cells of the body during an infection and it can inhibit viruses from spreading to neighboring cells. It can aid in destroying cancerous cells. Interferon therapy takes advantage of these natural protective properties. Commercial interferon is used as a treatment for viral infections, such as hepatitis C, and as a treatment for certain cancers.

Interferon therapy is used to treat patients suffering from malignant melanoma that has spread to lymph nodes. It has been shown to reduce the rate of recurrence in patients with melanoma, and can be used to treat other cancers, mainly leukemia and lymphoma.

 


Sponsors of the Day

 

The QualityStocks Public Company Sponsor News

Micro Identification Technologies Inc. (MIT) (MMTC) MIT Initiates Expansion Plans Enabled by Recently Completed Manufacturing and Financing Agreements

QualityStocks


 

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336